Prediction: This Will Be the Best Pharmaceutical Stock to Own Over the Next 10 Years

So far in 2024, the healthcare sector has returned 8.5%. This is roughly on par with the long-term average return of the S&P 500. While that's not too shabby, growth investors may be looking for something a little more enticing.Within the broader healthcare sector, the drug manufacturers market has generated a return of 14.3% so far in 2024 and 17.3% over the last year. One of the biggest players among drug manufacturers is Eli Lilly (NYSE: LLY). With shares up 82% over the last 12 months, Lilly looks absolutely unstoppable.Despite this meteoric rise, I think Lilly's gains are just getting started. Let's break down what's fueling Lilly's growth right now, and explore why the company's future prospects look bright.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool